These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 24333978
1. [Evaluation of thrombocytosis as predictive factor in colorectal cancer]. Baranyai Z, Jósa V, Krzystanek M, Eklund AC, Szász AM, Szállási Z. Magy Seb; 2013 Dec; 66(6):331-7. PubMed ID: 24333978 [Abstract] [Full Text] [Related]
2. The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer. Baranyai Z, Krzystanek M, Jósa V, Dede K, Agoston E, Szász AM, Sinkó D, Szarvas V, Salamon F, Eklund AC, Szállási Z, Jakab F. Thromb Haemost; 2014 Mar 03; 111(3):483-90. PubMed ID: 24285160 [Abstract] [Full Text] [Related]
3. Elevation of platelet count in patients with colorectal cancer predicts tendency to metastases and poor prognosis. Lin MS, Huang JX, Zhu J, Shen HZ. Hepatogastroenterology; 2012 Sep 03; 59(118):1687-90. PubMed ID: 22591645 [Abstract] [Full Text] [Related]
4. Relationship of postoperative thrombocytosis and survival of patients with colorectal cancer. Josa V, Krzystanek M, Eklund AC, Salamon F, Zarand A, Szallasi Z, Baranyai Z. Int J Surg; 2015 Jun 03; 18():1-6. PubMed ID: 25843227 [Abstract] [Full Text] [Related]
10. Impact of pretreatment thrombocytosis on survival in primary breast cancer. Taucher S, Salat A, Gnant M, Kwasny W, Mlineritsch B, Menzel RC, Schmid M, Smola MG, Stierer M, Tausch C, Galid A, Steger G, Jakesz R, Austrian Breast and Colorectal Cancer Study Group. Thromb Haemost; 2003 Jun 03; 89(6):1098-106. PubMed ID: 12783124 [Abstract] [Full Text] [Related]
11. [The occurrence and impact on survival of type 2 diabetes mellitus and thrombocytosis in colorectal cancer, before and after the surgical resection of the primary tumor]. Herold Z, Ambrus V, Herold M, Herczeg G, Igaz P, Harsányi L, Somogyi A. Orv Hetil; 2018 May 03; 159(19):756-767. PubMed ID: 29730943 [Abstract] [Full Text] [Related]
12. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen. Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K. Ann Surg Oncol; 2012 Oct 03; 19(11):3422-31. PubMed ID: 22576063 [Abstract] [Full Text] [Related]
13. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients. Song A, Eo W, Lee S. World J Gastroenterol; 2015 Nov 21; 21(43):12410-20. PubMed ID: 26604648 [Abstract] [Full Text] [Related]
19. The Prognostic Significance of Pretreatment Hematologic Parameters in Patients Undergoing Resection for Colorectal Cancer. Kozak MM, von Eyben R, Pai JS, Anderson EM, Welton ML, Shelton AA, Kin C, Koong AC, Chang DT. Am J Clin Oncol; 2017 Aug 21; 40(4):405-412. PubMed ID: 25756348 [Abstract] [Full Text] [Related]
20. The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer. Ozawa T, Ishihara S, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Hata K, Kawai K, Nozawa H, Kazama S, Yamaguchi H, Sunami E, Kitayama J, Watanabe T. Int J Colorectal Dis; 2015 Sep 21; 30(9):1165-71. PubMed ID: 26049902 [Abstract] [Full Text] [Related] Page: [Next] [New Search]